FOSL2 and pulmonary hypertension: Regarding pulmonary hypertension (PH), a significant reduction (20.3%, p = 0.019) of right ventricular systolic pressure (RVSP) was observed in Fra-2 Tg mice treated with acazicolcept compared to Fra-2 Tg mice that received Fc control treatment.